share_log

回盛生物(300871.SZ):前三季度净亏损4765.83万元

Wuhan Hvsen Biotechnology (300871.SZ): a net loss of 47.6583 million yuan in the first three quarters.

Gelonghui Finance ·  Oct 29 17:24

Gelonghui, October 29th - Wuhan Hvsen Biotechnology (300871.SZ) released the third quarter report for 2024, achieving revenue of 0.793 billion yuan in the first three quarters, a year-on-year growth of 14.63%; net income attributable to shareholders of the listed company was -47.6583 million yuan; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was -32.3973 million yuan; basic earnings per share was -0.29 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment